Loading insider details...
Beta
Latest Form 4 (Jun 22, 2026): Grant/Award of 35,700 AKBA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 35,700 | n/a |
| Jun 11, 2025 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 35,700 | n/a |
| Jan 22, 2025 | Akebia Therapeutics, Inc. (AKBA) | Exercise/Conversion | 20,100 | $9.0K |
| Jun 10, 2024 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 30,000 | n/a |
| Jun 8, 2023 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 30,000 | n/a |
| Jun 9, 2022 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 13,700 | n/a |
| Nov 3, 2021 | Akebia Therapeutics, Inc. (AKBA) | Grant/Award | 80,200 | n/a |